{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T05:52:22Z","timestamp":1792043542596,"version":"4.4.0"},"reference-count":62,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,8,22]],"date-time":"2013-08-22T00:00:00Z","timestamp":1377129600000},"content-version":"vor","delay-in-days":599,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Value in Health"],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1016\/j.jval.2011.11.007","type":"journal-article","created":{"date-parts":[[2012,1,27]],"date-time":"2012-01-27T14:57:51Z","timestamp":1327676271000},"page":"S29-S34","source":"Crossref","is-referenced-by-count":42,"special_numbering":"S","title":["Cost and Effectiveness Evaluation of Prophylactic HPV Vaccine in Developing Countries"],"prefix":"10.1016","volume":"15","author":[{"given":"Wichai","family":"Termrungruanglert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piyalamporn","family":"Havanond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nipon","family":"Khemapech","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Somrat","family":"Lertmaharit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sathirakorn","family":"Pongpanich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chonlakiet","family":"Khorprasert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Surasak","family":"Taneepanichskul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jval.2011.11.007_bib1","first-page":"519","article-title":"Cancer in developing countries","volume":"19\u201320","author":"Parkin","year":"1994","journal-title":"Cancer Surv"},{"key":"10.1016\/j.jval.2011.11.007_bib2","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1002\/(SICI)1097-0215(19990315)80:6<827::AID-IJC6>3.0.CO;2-P","article-title":"Estimates of the worldwide incidence of 25 major cancers in 1990","volume":"80","author":"Parkin","year":"1999","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jval.2011.11.007_bib3","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1002\/ijc.2910550604","article-title":"Estimates of the worldwide mortality from eighteen major cancers in 1985: implications for prevention and projections of future burden","volume":"55","author":"Pisani","year":"1993","journal-title":"Int J Cancer"},{"issue":"Suppl. 1","key":"10.1016\/j.jval.2011.11.007_bib4","doi-asserted-by":"crossref","first-page":"S59","DOI":"10.1038\/sj.bjc.6604589","article-title":"Survival from cancer of the uterine cervix in England and Wales up to 2001","volume":"99","author":"Quinn","year":"2008","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jval.2011.11.007_bib5","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1093\/jnci\/87.11.796","article-title":"Prevalence of human papillomavirus in cervical cancer: a worldwide perspective","volume":"87","author":"Bosch","year":"1995","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.jval.2011.11.007_bib6","first-page":"251","article-title":"HPV and cervical neoplasia: review of case\u2013control and cohort studies","volume":"119","author":"Munoz","year":"1992","journal-title":"IARC Sci Publ"},{"key":"10.1016\/j.jval.2011.11.007_bib7","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F","article-title":"Human papillomavirus is a necessary cause of invasive cervical cancer worldwide","volume":"189","author":"Walboomers","year":"1999","journal-title":"J Pathol"},{"key":"10.1016\/j.jval.2011.11.007_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/CMR.16.1.1-17.2003","article-title":"Human papillomavirus and cervical cancer","volume":"16","author":"Burd","year":"2003","journal-title":"Clin Microbiol Rev"},{"issue":"Suppl. 3","key":"10.1016\/j.jval.2011.11.007_bib9","article-title":"Chapter 3: HPV type-distribution in women with and without cervical neoplastic diseases","volume":"24","author":"Clifford","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.jval.2011.11.007_bib10","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/sj.bjc.6601024","article-title":"Comparison of HPV type distribution in high-grade cervical lesions and cervical cancer: a meta-analysis","volume":"89","author":"Clifford","year":"2003","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jval.2011.11.007_bib11","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/j.1479-828X.2006.00580.x","article-title":"Human papillomavirus infection: an old disease, a new vaccine","volume":"46","author":"Giles","year":"2006","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"10.1016\/j.jval.2011.11.007_bib12","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1093\/jnci\/djh104","article-title":"Projected clinical benefits and cost-effectiveness of a human papillomavirus 16\/18 vaccine","volume":"96","author":"Goldie","year":"2004","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.jval.2011.11.007_bib13","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1056\/NEJMoa021641","article-title":"Epidemiologic classification of human papillomavirus types associated with cervical cancer","volume":"348","author":"Munoz","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jval.2011.11.007_bib14","series-title":"Cancer in Thailand 1992-1994","article-title":"Cervix uteri","author":"Deerasamee","year":"1999"},{"key":"10.1016\/j.jval.2011.11.007_bib15","series-title":"Cancer in Thailand (Vol. III)","article-title":"Cervix uteri","author":"Pengsaa","year":"1997"},{"key":"10.1016\/j.jval.2011.11.007_bib16","first-page":"146","article-title":"Cervical cancer incidence in the south of Thailand 1988\u20131989","volume":"76","author":"Chichareon","year":"1993","journal-title":"J Med Assoc Thai"},{"issue":"Suppl. 2","key":"10.1016\/j.jval.2011.11.007_bib17","doi-asserted-by":"crossref","first-page":"S46","DOI":"10.1016\/j.ijgo.2005.01.010","article-title":"Advocating for cervical cancer prevention","volume":"89","author":"Sherris","year":"2005","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.jval.2011.11.007_bib18","series-title":"Vital Statistics","year":"2008"},{"key":"10.1016\/j.jval.2011.11.007_bib19","series-title":"Cancer in Thailand","article-title":"Projection of cancer problems","author":"Sriplung","year":"2008"},{"key":"10.1016\/j.jval.2011.11.007_bib20","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3802\/jgo.2009.20.2.81","article-title":"Epidemiologic report of gynecologic cancer in Thailand","volume":"20","author":"Wilailak","year":"2009","journal-title":"J Gynecol Oncol"},{"key":"10.1016\/j.jval.2011.11.007_bib21","first-page":"507","article-title":"Detection and typing of human papillomavirus in cervical intraepitherial neoplasia (CIN) grade III by PCR and dot hybridization","volume":"29","author":"Lertworapreecha","year":"1998","journal-title":"Southeast Asian J Trop Med Public Health"},{"key":"10.1016\/j.jval.2011.11.007_bib22","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1006\/scbi.1999.0147","article-title":"Human papillomavirus vaccines","volume":"9","author":"Breitburd","year":"1999","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.jval.2011.11.007_bib23","doi-asserted-by":"crossref","first-page":"7236","DOI":"10.1016\/j.vaccine.2009.05.019","article-title":"WHO position on HPV vaccines","volume":"27","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.jval.2011.11.007_bib24","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1093\/aje\/kwj077","article-title":"Modeling the sexual transmissibility of human papillomavirus infection using stochastic computer simulation and empirical data from a cohort study of young women in Montreal, Canada","volume":"163","author":"Burchell","year":"2006","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.jval.2011.11.007_bib25","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1002\/cncr.11680","article-title":"Decision science and cervical cancer","volume":"98","author":"Cantor","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.jval.2011.11.007_bib26","doi-asserted-by":"crossref","first-page":"97","DOI":"10.7326\/0003-4819-130-2-199901190-00003","article-title":"The costs, clinical benefits, and cost-effectiveness of screening for cervical cancer in HIV-infected women","volume":"130","author":"Goldie","year":"1999","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jval.2011.11.007_bib27","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.1001\/jama.287.18.2382","article-title":"Cost-effectiveness of alternative triage strategies for atypical squamous cells of undetermined significance","volume":"287","author":"Kim","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.jval.2011.11.007_bib28","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1001\/jama.290.6.781","article-title":"Potential health and economic impact of adding a human papillomavirus vaccine to screening programs","volume":"290","author":"Kulasingam","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.jval.2011.11.007_bib29","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1001\/jama.287.18.2372","article-title":"Benefits and costs of using HPV testing to screen for cervical cancer","volume":"287","author":"Mandelblatt","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.jval.2011.11.007_bib30","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1093\/jnci\/94.19.1469","article-title":"Costs and benefits of different strategies to screen for cervical cancer in less-developed countries","volume":"94","author":"Mandelblatt","year":"2002","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.jval.2011.11.007_bib31","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1093\/oxfordjournals.aje.a010166","article-title":"Mathematical model for the natural history of human papillomavirus infection and cervical carcinogenesis","volume":"151","author":"Myers","year":"2000","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.jval.2011.11.007_bib32","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3201\/eid0901.020168","article-title":"Cost-effectiveness of a potential vaccine for human papillomavirus","volume":"9","author":"Sanders","year":"2003","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.jval.2011.11.007_bib33","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.3201\/eid1011.040222","article-title":"Evaluating human papillomavirus vaccination programs","volume":"10","author":"Taira","year":"2004","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.jval.2011.11.007_bib34","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1177\/0272989X8500500205","article-title":"Probabilistic sensitivity analysis using Monte Carlo simulation: a practical approach","volume":"5","author":"Doubilet","year":"1985","journal-title":"Med Decis Making"},{"key":"10.1016\/j.jval.2011.11.007_bib35","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1177\/0272989X9301300409","article-title":"Markov models in medical decision making: a practical guide","volume":"13","author":"Sonnenber","year":"1993","journal-title":"Med Decis Making"},{"key":"10.1016\/j.jval.2011.11.007_bib36","series-title":"Estimation generation life tables for Thailand of five-year birth cohorts: 1900\u20132000","author":"Prasartkul","year":"2002"},{"key":"10.1016\/j.jval.2011.11.007_bib37","series-title":"Cancer in Thailand (Vol. IV)","article-title":"Cervix uteri","author":"Srivatanakul","year":"2000"},{"key":"10.1016\/j.jval.2011.11.007_bib38","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ajog.2004.01.043","article-title":"Diagnoses and outcomes in cervical cancer screening: a population-based study","volume":"191","author":"Insinga","year":"2004","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jval.2011.11.007_bib39","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1136\/sti.2009.040188","article-title":"Genital warts incidence and health care resource utilisation in Australia","volume":"86","author":"Pirotta","year":"2010","journal-title":"Sex Transm Infect"},{"key":"10.1016\/j.jval.2011.11.007_bib40","first-page":"21","article-title":"Cervical cancer survival at Pramongkutklao Hospital","volume":"48","author":"Tanapat","year":"1995","journal-title":"Royal Thai Army Med J"},{"issue":"Suppl. 1","key":"10.1016\/j.jval.2011.11.007_bib41","first-page":"15","article-title":"Cervical cancer survival at Ramathibodi Hospital 1979\u20131983","volume":"73","author":"Srisupundit","year":"1990","journal-title":"J Med Assoc Thai"},{"key":"10.1016\/j.jval.2011.11.007_bib42","first-page":"29","article-title":"Prognostic factors for survival after surgery for early stages cervical cancer","volume":"2","author":"Pengsaa","year":"1990","journal-title":"Thai J Obstet Gynaecol"},{"key":"10.1016\/j.jval.2011.11.007_bib43","first-page":"25","article-title":"Five year results of radiation therapy and radiation therapy with concomitant high dose Mitomycin-C in the treatment of the uterine cervix","volume":"7","author":"Kongthanarat","year":"1996","journal-title":"J Rajavithi Hosp"},{"key":"10.1016\/j.jval.2011.11.007_bib44","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s11604-006-0082-6","article-title":"Outcomes in 24 selected patients with stage IVB cervical cancer and excellent performance status treated with radiotherapy and chemotherapy","volume":"24","author":"Zighelboim","year":"2006","journal-title":"Radiat Med"},{"key":"10.1016\/j.jval.2011.11.007_bib45","first-page":"S216","article-title":"Results of radiation therapy in stage IB cervical carcinoma at King Chulalongkorn Memorial Hospital: fifteen-year experience","volume":"84","author":"Lertbutsayanukul","year":"2001","journal-title":"J Med Assoc Thai"},{"key":"10.1016\/j.jval.2011.11.007_bib46","first-page":"497","article-title":"Analysis of the clinicopathological prognosis of stage IVb cervical carcinoma","volume":"19","author":"Nishio","year":"2008","journal-title":"Oncol Rep"},{"key":"10.1016\/j.jval.2011.11.007_bib47","first-page":"170","article-title":"Recurrent cervical intraepithelial neoplasia in human immunodeficiency virus-seropositive women","volume":"82","author":"Maiman","year":"1993","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jval.2011.11.007_bib48","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1177\/030089160409000211","article-title":"Persistent human papilloma virus infection as an indicator of risk of recurrence of high-grade cervical intraepithelial neoplasia treated by the loop electrosurgical excision procedure","volume":"90","author":"Cecchini","year":"2004","journal-title":"Tumori"},{"key":"10.1016\/j.jval.2011.11.007_bib49","first-page":"5","article-title":"An evidence-based review of medical and surgical treatments of genital warts","volume":"12","author":"Scheinfeld","year":"2006","journal-title":"Dermatol Online J"},{"key":"10.1016\/j.jval.2011.11.007_bib50","first-page":"69","article-title":"The prevalence of human papillomavirus in cervical cancer in Iran","volume":"3","author":"Mortazavi","year":"2000","journal-title":"Asian Pacific J Cancer Prev"},{"key":"10.1016\/j.jval.2011.11.007_bib51","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0020-7292(94)90021-3","article-title":"Genital human papillomavirus infections in Taiwan","volume":"44","author":"Tsao","year":"1994","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.jval.2011.11.007_bib52","article-title":"Quality of life in Thai women diagnosed with genital wart, cervical cancer and cervical intraepithelial neoplasia at King Chulalongkorn Memorial Hospital","author":"Khemapech","year":"2010","journal-title":"ISPOR 4th Asia-Pacific Conference, Phuket, Thailand, September 5\u20137"},{"key":"10.1016\/j.jval.2011.11.007_bib53","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S1470-2045(05)70101-7","article-title":"Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial","volume":"6","author":"Villa","year":"2005","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jval.2011.11.007_bib54","series-title":"Cost-Effectiveness in Health and Medicine","author":"Gold","year":"1996"},{"key":"10.1016\/j.jval.2011.11.007_bib55","series-title":"Presented at the 6th annual meeting of the HTA","article-title":"The role of HTA in the development of HPV vaccination policy in Thailand","author":"Tantivess","year":"2009"},{"key":"10.1016\/j.jval.2011.11.007_bib56","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1097\/00001648-200211000-00006","article-title":"The theoretical population-level impact of a prophylactic human papilloma virus vaccine","volume":"13","author":"Hughes","year":"2002","journal-title":"Epidemiology"},{"key":"10.1016\/j.jval.2011.11.007_bib57","series-title":"World Development Indicators","year":"2009"},{"key":"10.1016\/j.jval.2011.11.007_bib58","series-title":"Macroeconomic and Health","year":"2001"},{"key":"10.1016\/j.jval.2011.11.007_bib59","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1056\/NEJM199808063390606","article-title":"Gains in life expectancy from medical interventions--standardizing data on outcomes","volume":"339","author":"Wright","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jval.2011.11.007_bib60","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1056\/NEJMoa061741","article-title":"Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions","volume":"356","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jval.2011.11.007_bib61","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1016\/S0140-6736(06)68439-0","article-title":"Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial","volume":"367","author":"Harper","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.jval.2011.11.007_bib62","series-title":"Presented at 41st annual meeting of Society of Gynecologic Oncologists (SGO)","first-page":"433","article-title":"Impact of the quadrivalent HPV 6\/11\/16\/1\/vaccine in women who have undergone definitive therapy: do these women benefit from vaccination?","author":"Huh","year":"2010"}],"container-title":["Value in Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098301511035443?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098301511035443?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,22]],"date-time":"2019-06-22T20:03:15Z","timestamp":1561233795000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1098301511035443"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1]]},"references-count":62,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,1]]}},"alternative-id":["S1098301511035443"],"URL":"https:\/\/doi.org\/10.1016\/j.jval.2011.11.007","relation":{},"ISSN":["1098-3015"],"issn-type":[{"value":"1098-3015","type":"print"}],"subject":[],"published":{"date-parts":[[2012,1]]}}}